A Serum Protein Classifier Identifying Patients with Advanced Non-Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint Inhibitors

M Muller; K Hummelink; Daan Hurkmans; ALN Niemeijer; K Monkhorst; J Roder; C Oliveira; H Roder; Joachim Aerts; EF Smit

doi:10.1158/1078-0432.Ccr-20-0538

A Serum Protein Classifier Identifying Patients with Advanced Non-Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint Inhibitors

M Muller, K Hummelink, Daan Hurkmans, ALN Niemeijer, K Monkhorst, J Roder, C Oliveira, H Roder, Joachim Aerts, EF Smit

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

14 Citations (Scopus)

Original language	English
Pages (from-to)	5188-5197
Number of pages	10
Journal	Clinical Cancer Research
Volume	26
Issue number	19
DOIs	https://doi.org/10.1158/1078-0432.Ccr-20-0538
Publication status	Published - 2020

Research programs

EMC MM-04-42-02

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.Ccr-20-0538

http://hdl.handle.net/1765/131397

Cite this

Muller, M., Hummelink, K., Hurkmans, D., Niemeijer, ALN., Monkhorst, K., Roder, J., Oliveira, C., Roder, H., Aerts, J., & Smit, EF. (2020). A Serum Protein Classifier Identifying Patients with Advanced Non-Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint Inhibitors. Clinical Cancer Research, 26(19), 5188-5197. https://doi.org/10.1158/1078-0432.Ccr-20-0538

@article{1f7cbb1ec77b4eb3a519cccc0efe0260,

title = "A Serum Protein Classifier Identifying Patients with Advanced Non-Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint Inhibitors",

author = "M Muller and K Hummelink and Daan Hurkmans and ALN Niemeijer and K Monkhorst and J Roder and C Oliveira and H Roder and Joachim Aerts and EF Smit",

year = "2020",

doi = "10.1158/1078-0432.Ccr-20-0538",

language = "English",

volume = "26",

pages = "5188--5197",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "19",

}

Muller, M, Hummelink, K, Hurkmans, D, Niemeijer, ALN, Monkhorst, K, Roder, J, Oliveira, C, Roder, H, Aerts, J & Smit, EF 2020, 'A Serum Protein Classifier Identifying Patients with Advanced Non-Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint Inhibitors', Clinical Cancer Research, vol. 26, no. 19, pp. 5188-5197. https://doi.org/10.1158/1078-0432.Ccr-20-0538

TY - JOUR

T1 - A Serum Protein Classifier Identifying Patients with Advanced Non-Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint Inhibitors

AU - Muller, M

AU - Hummelink, K

AU - Hurkmans, Daan

AU - Niemeijer, ALN

AU - Monkhorst, K

AU - Roder, J

AU - Oliveira, C

AU - Roder, H

AU - Aerts, Joachim

AU - Smit, EF

PY - 2020

Y1 - 2020

U2 - 10.1158/1078-0432.Ccr-20-0538

DO - 10.1158/1078-0432.Ccr-20-0538

M3 - Article

SN - 1078-0432

VL - 26

SP - 5188

EP - 5197

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 19

ER -